NCT06476821View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of Single Doses of BMS-986435 (MYK-224) in Healthy Chinese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 27, 2024

Primary Completion Date

October 11, 2024

Study Completion Date

October 11, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

BMS-986435

Specified dose on specified days

Trial Locations (1)

200032

Local Institution - 0001, Xuhui District

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY